Clinical trials
Sarcoma trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 9 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 9 |
| Eli Lilly and Company | 4 |
| Rigshospitalet, Denmark | 3 |
| Bayer | 2 |
| Eisai Inc. | 2 |
| European Paediatric Soft Tissue Sarcoma Study Group | 2 |
| Novartis Pharmaceuticals | 2 |
| Turning Point Therapeutics, Inc. | 2 |
| Valerio Therapeutics | 2 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 39 |
| Hemangiosarcoma | 11 |
| Fibrosarcoma | 10 |
| Histiocytoma, Malignant Fibrous | 10 |
| Leiomyosarcoma | 10 |
| Liposarcoma | 10 |
| Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neurofibrosarcoma | 7 |
| Sarcoma, Synovial | 7 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.